Henri Kornmann

Henri Kornmann is an experienced professional in the biotech and pharmaceutical industries, currently serving as Senior Director and Head of the Biologics Innovation Centre at Ferring Pharmaceuticals since January 2019, where leadership in CMC development for biologics, including monoclonal antibody derivatives and gene therapy products, is prioritized. Previous roles include Director of Biologics Development at Ferring, Head of Manufacturing Operations at Biogen, Operations Director at Medtronic, and various leadership positions at Merck Serono, focusing on biosimilars and biotechnology production. Kornmann began a career at Serono as a Scientist in Bioprocesses Development and has a solid academic foundation with a PhD in Bioprocess Engineering and additional credentials in Lean Six Sigma and Business Administration from prestigious institutions.